Literature DB >> 27326663

Interventional MR Imaging for Deep-Brain Stimulation Electrode Placement.

Thanissara Chansakul1, Paul N Chen1, Thomas C Lee1, Travis Tierney1.   

Abstract

Purpose To investigate the safety and targeting errors of deep-brain stimulation (DBS) electrodes placed under interventional magnetic resonance (MR) imaging, which allows near real-time anatomic placement without physiologic mapping. Materials and Methods Retrospectively evaluated were 10 consecutive patients (five women, five men) with a mean age of 59.9 years (age range, 17-79 years). These patients underwent interventional MR imaging-guided DBS placement for movement disorders from September 2013 to August 2014 for placement of 19 DBS electrodes in cases where traditional frame-based surgery may be challenging because of the following: dystonia resulting in difficulty in placing the patients in frame, patient's inability or unwillingness to tolerate awake surgery, or anatomic anomaly or variant that could increase the risk of bleeding from microelectrode mapping. Outcomes measured included perioperative hemorrhage, death, and stroke, and electrode functionality assessed at 2 weeks after the operation. In addition, the mean radial error and mean trajectory error were calculated. Results No intraoperative neurologic complications (n = 10 [95% confidence interval: 0%, 31%]) were observed. One patient developed aspiration pneumonia in the postoperative period. Mean radial error was 0.7 mm ± 0.4 (standard deviation) and mean trajectory error was 0.5 mm ± 0.4. All leads delivered clinically effective stimulation. Conclusion Interventional MR imaging-guided DBS electrode placement may be a safe and effective alternative to conventional frame-based surgery in well-selected patients. © RSNA, 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27326663      PMCID: PMC5131831          DOI: 10.1148/radiol.2015151136

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus.

Authors:  P Coubes; A Roubertie; N Vayssiere; S Hemm; B Echenne
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

2.  Assessment of brain shift related to deep brain stimulation surgery.

Authors:  Muhammad Faisal Khan; Klaus Mewes; Robert E Gross; Oskar Skrinjar
Journal:  Stereotact Funct Neurosurg       Date:  2007-09-18       Impact factor: 1.875

Review 3.  Some recent trends and further promising directions in functional neurosurgery.

Authors:  Travis S Tierney; Tejas Sankar; Andres M Lozano
Journal:  Acta Neurochir Suppl       Date:  2013

4.  An optimized system for interventional magnetic resonance imaging-guided stereotactic surgery: preliminary evaluation of targeting accuracy.

Authors:  Paul S Larson; Philip A Starr; Geoffrey Bates; Lisa Tansey; R Mark Richardson; Alastair J Martin
Journal:  Neurosurgery       Date:  2012-03       Impact factor: 4.654

5.  Long-term benefits in quality of life after unilateral thalamic deep brain stimulation for essential tremor.

Authors:  Jules M Nazzaro; Rajesh Pahwa; Kelly E Lyons
Journal:  J Neurosurg       Date:  2012-04-20       Impact factor: 5.115

6.  Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position.

Authors:  Jürgen Voges; Jens Volkmann; Niels Allert; Ralph Lehrke; Athanasios Koulousakis; Hans-Joachim Freund; Volker Sturm
Journal:  J Neurosurg       Date:  2002-02       Impact factor: 5.115

7.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

8.  Interventional MRI-guided deep brain stimulation in pediatric dystonia: first experience with the ClearPoint system.

Authors:  Philip A Starr; Leslie C Markun; Paul S Larson; Monica M Volz; Alastair J Martin; Jill L Ostrem
Journal:  J Neurosurg Pediatr       Date:  2014-08-01       Impact factor: 2.375

9.  Incidence of symptomatic hemorrhage after stereotactic electrode placement.

Authors:  Charles A Sansur; Robert C Frysinger; Nader Pouratian; Kai-Ming Fu; Markus Bittl; Rod J Oskouian; Edward R Laws; W Jeffrey Elias
Journal:  J Neurosurg       Date:  2007-11       Impact factor: 5.115

10.  Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations.

Authors:  Philip A Starr; Chadwick W Christine; Philip V Theodosopoulos; Nadja Lindsey; Deborah Byrd; Anthony Mosley; William J Marks
Journal:  J Neurosurg       Date:  2002-08       Impact factor: 5.115

View more
  4 in total

1.  Development and testing of implanted carbon electrodes for electromagnetic field mapping during neuromodulation.

Authors:  Neeta Ashok Kumar; Munish Chauhan; Sri Kirthi Kandala; Sung-Min Sohn; Rosalind J Sadleir
Journal:  Magn Reson Med       Date:  2020-04-16       Impact factor: 4.668

Review 2.  Challenges and opportunities for brainstem neuroimaging with ultrahigh field MRI.

Authors:  Roberta Sclocco; Florian Beissner; Marta Bianciardi; Jonathan R Polimeni; Vitaly Napadow
Journal:  Neuroimage       Date:  2017-02-21       Impact factor: 6.556

Review 3.  Brainstem neuroimaging of nociception and pain circuitries.

Authors:  Vitaly Napadow; Roberta Sclocco; Luke A Henderson
Journal:  Pain Rep       Date:  2019-08-07

4.  Measuring Subthalamic Nucleus Volume of Parkinson's Patients and Evaluating Its Relationship with Clinical Scales at Pre- and Postdeep Brain Stimulation Treatment: A Magnetic Resonance Imaging Study.

Authors:  Li Lu; Kai Xu; Lin Shi; Weiqiang Dou; Kai Liu; Hong Ma; Lixiang Xie; Chao Zhang; Cailuan Lu
Journal:  Biomed Res Int       Date:  2021-02-25       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.